Gilead Sciences – Inaugural ESG Impact Report
Gilead Sciences has published its first Environmental, Social, and Governance (ESG) Impact Report. This is an update of our usual Year in Review, and it leverages the ESG framework to showcase the previous year’s triumphs and achievements.
Though the report is new, our dedication to ESG is not: we’ve been led by Environmental, Social, and Governance principles for over 35 years.
Gilead has long operated with industry-leading ESG principles as an inherent part of our company, and we’re pleased to report that we continued to demonstrate our leadership during 2022, including:
LEED Platinum accreditation for our Foster City Wellbeing Center and LEED Silver certification for two other U.S. locations
A flawless score on The Human Rights Campaign’s Corporate Equality Index for the sixth year in a row.
The US Patent and Trademark Office awarded us the Patent for Humanity Award for our COVID-19 access tactics and dedication to global fairness and reaching as many patients as possible at the height of the epidemic.
Corporate Knights named the Dow Jones Sustainability World Index #1 most sustainable biotech in the world for the second straight year.